Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Rothman

Showing results (41-50 of 360) with videos related to

Pageof 36
Sort By:
Journal of Occupational and Environmental Medicine|February 4, 2017
Reanalysis of Reported Associations of Beryllium and Lung Cancer in a Large Occupational CohortPaul L Mosquin, Kenneth J Rothman
Journal of the American College of Cardiology|October 25, 2023
Initial Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion: Shifting Approaches to a Moving TargetJonathan L Halperin, Kenneth J Rothman
European Journal of Epidemiology|July 6, 2018
Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysisMarco Vinceti, Tommaso Filippini, Kenneth J Rothman
European Journal of Epidemiology|April 20, 2011
Rebuilding bridges: what is the real role of social class in disease occurrence?Kenneth J Rothman, Zena Stein, Mervyn Susser
Journal of Clinical Epidemiology|January 30, 2008
Pharmacoepidemiology and "in silico" drug evaluation: is there common ground?Til Stürmer, Kenneth J Rothman, Jerry Avorn
Pharmacoepidemiology and Drug Safety|August 19, 2004
The reporting odds ratio and its advantages over the proportional reporting ratioKenneth J Rothman, Stephan Lanes, Susan T Sacks
The Journal of Infectious Diseases|February 16, 2006
Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusceptionKenneth J Rothman, Yinong Young-Xu, Felix Arellano
Pharmacoepidemiology and Drug Safety|March 11, 2006
Insights into different results from different causal contrasts in the presence of effect-measure modificationTil Stürmer, Kenneth J Rothman, Robert J Glynn
Journal of Clinical Epidemiology|November 24, 2025
Hill's considerations are not causal criteriaDavid A Savitz, Neil Pearce, Kenneth J Rothman
IRB|March 1, 1985
IRB jurisdiction and limits on IRB actionsNathan Hershey, Cristina I Cann, Kenneth J Rothman
Pageof 36

Showing results (41-50 of 360) with videos related to

Sort By:
Pageof 36
Journal of Occupational and Environmental Medicine|February 4, 2017
Reanalysis of Reported Associations of Beryllium and Lung Cancer in a Large Occupational CohortPaul L Mosquin, Kenneth J Rothman
Journal of the American College of Cardiology|October 25, 2023
Initial Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion: Shifting Approaches to a Moving TargetJonathan L Halperin, Kenneth J Rothman
European Journal of Epidemiology|July 6, 2018
Selenium exposure and the risk of type 2 diabetes: a systematic review and meta-analysisMarco Vinceti, Tommaso Filippini, Kenneth J Rothman
European Journal of Epidemiology|April 20, 2011
Rebuilding bridges: what is the real role of social class in disease occurrence?Kenneth J Rothman, Zena Stein, Mervyn Susser
Journal of Clinical Epidemiology|January 30, 2008
Pharmacoepidemiology and "in silico" drug evaluation: is there common ground?Til Stürmer, Kenneth J Rothman, Jerry Avorn
Pharmacoepidemiology and Drug Safety|August 19, 2004
The reporting odds ratio and its advantages over the proportional reporting ratioKenneth J Rothman, Stephan Lanes, Susan T Sacks
The Journal of Infectious Diseases|February 16, 2006
Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusceptionKenneth J Rothman, Yinong Young-Xu, Felix Arellano
Pharmacoepidemiology and Drug Safety|March 11, 2006
Insights into different results from different causal contrasts in the presence of effect-measure modificationTil Stürmer, Kenneth J Rothman, Robert J Glynn
Journal of Clinical Epidemiology|November 24, 2025
Hill's considerations are not causal criteriaDavid A Savitz, Neil Pearce, Kenneth J Rothman
IRB|March 1, 1985
IRB jurisdiction and limits on IRB actionsNathan Hershey, Cristina I Cann, Kenneth J Rothman
Pageof 36